Our approved medicines

Our approved medicines

Akcea Therapeutics, a wholly-owned subsidiary of Ionis Pharmaceuticals, was established in early 2015 and is headquartered in Boston, Massachusetts. Akcea Therapeutics developed an initial presence in the UK in October 2016 and a UK and European head office in Surrey in 2018.

To date, we have two medicines with regulatory approvals in many countries, including the UK.